ArticleInternational journal of cardiology. Cardiovascular risk and prevention2026
Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.
George A Blankson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.